These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24570185)
1. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185 [TBL] [Abstract][Full Text] [Related]
2. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population. Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350 [TBL] [Abstract][Full Text] [Related]
3. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis. Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185 [TBL] [Abstract][Full Text] [Related]
5. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population. Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083 [TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population. Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522 [TBL] [Abstract][Full Text] [Related]
7. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis. Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525 [TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692 [TBL] [Abstract][Full Text] [Related]
9. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan. Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902 [TBL] [Abstract][Full Text] [Related]
10. A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population. Aytekin T; Aytekin A; Maralcan G; Gokalp MA; Ozen D; Borazan E; Yilmaz L Asian Pac J Cancer Prev; 2014; 15(17):7181-5. PubMed ID: 25227811 [TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study. Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B Cancer Epidemiol; 2010 Jun; 34(3):298-302. PubMed ID: 20347627 [TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis. Zhao Y; He HR; Wang MY; Ren XD; Zhang L; Dong YL; Lu J Genet Mol Res; 2015 May; 14(2):5171-80. PubMed ID: 26125710 [TBL] [Abstract][Full Text] [Related]
13. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors]. Yang SM; Shi YL Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects. Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184 [TBL] [Abstract][Full Text] [Related]
15. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients. Pandey A; Bahl C; Sharma S; Singh N; Behera D Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699 [TBL] [Abstract][Full Text] [Related]
16. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis. Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808 [TBL] [Abstract][Full Text] [Related]
17. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis. Xie M; Zhao F; Zou X; Jin S; Xiong S Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220 [TBL] [Abstract][Full Text] [Related]